These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27189155)

  • 1. The role of insulin pump therapy for type 2 diabetes mellitus.
    Landau Z; Raz I; Wainstein J; Bar-Dayan Y; Cahn A
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27189155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource utilization with insulin pump therapy for type 2 diabetes mellitus.
    Lynch PM; Riedel AA; Samant N; Fan Y; Peoples T; Levinson J; Lee SW
    Am J Manag Care; 2010; 16(12):892-6. PubMed ID: 21348559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EFFECTIVENESS OF PUMP INSULIN THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (REVIEW)].
    Seidinova A; Ishigov I; Peyami C; Seidinov S
    Georgian Med News; 2018 Nov; (284):51-55. PubMed ID: 30618389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous insulin infusion systems in type 2 diabetes.
    Kesavadev J
    J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes: insulin pump therapy for type 2 diabetes mellitus.
    Pickup JC
    Nat Rev Endocrinol; 2014 Nov; 10(11):647-9. PubMed ID: 25112234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience.
    Maurizi AR; Suraci C; Pitocco D; Schiaffini R; Tubili C; Morviducci L; Giordano R; Manfrini S; Lauro D; Frontoni S; Pozzilli P; Buzzetti R;
    J Diabetes; 2016 Jan; 8(1):41-4. PubMed ID: 26118939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Primer on Insulin Pump Therapy for Health Care Providers.
    McCrea DL
    Nurs Clin North Am; 2017 Dec; 52(4):553-564. PubMed ID: 29080577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
    Meneghini L; Sparrow-Bodenmiller J
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus.
    Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G
    J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin pump in type 2 diabetes: B-cell focused treatment].
    Picková K; Rušavý Z
    Vnitr Lek; 2017; 63(6):441-445. PubMed ID: 28840741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients for insulin pump therapy.
    Morrison G; Weston P
    Nurs Times; 2013 Mar 12-18; 109(10):14, 16, 18. PubMed ID: 23560341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
    Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
    Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.